Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival

The number of long-term survivors of high-risk neuroblastoma remains discouraging, with 10-year survival as low as 20%, despite decades of considerable international efforts to improve outcome. Major obstacles remain and include managing resistance to induction therapy, which causes tumor progressio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Thole, Theresa M, Lodrini, Marco, Fabian, Johannes, Wuenschel, Jasmin, Pfeil, Sebastian, Hielscher, Thomas, Kopp-Schneider, Annette, Heinicke, Ulrike, Fulda, Simone, Witt, Olaf, Eggert, Angelika, Fischer, Matthias, Deubzer, Hedwig E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386552/
https://ncbi.nlm.nih.gov/pubmed/28252645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.49
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados